Skip to content

The Rukhsa of Psychedelics in Shariah: Neural Correlates of Religious Experience and the Issue of License

Haroon Asghar

Figshare March 17, 2026 DOI: 10.6084/m9.figshare.31768987.v1 via OpenAlex

Summary

AI-generated from the abstract

Psychedelic medicines are distinct from intoxicants (khamr) because they do not impair moral judgment or rational faculties. Although unsupervised use remains impermissible due to psychological risks, therapeutic application may be justified under Islamic law through rukhsa (legal concession). Because psychedelics can mimic neural and phenomenological states produced in prayer or meditation, their clinical use may be permitted when such spiritual practices would otherwise serve as treatment, provided a threshold of disease severity or functional impairment is met.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Intervention Psychedelic medicines
Keywords Religious experience License Prayer Consciousness Islam
Key finding Psychedelic medicines differ from intoxicants and may be permissible for therapeutic use under Islamic law when they mimic spiritual practices like prayer or meditation and a disease severity threshold is met.

Abstract

A previous paper by the same author demonstrates that psychedelic medicines differ from intoxicants (khamr) as they do not induce moral impairment or “veil” rational faculties. While unsupervised should remain impermissible due to psychological risks, their therapeutic application may be justified under Islamic law through rukhsa (legal concession). Since psychedelics can mimic neural and phenomenological states which are produced in prayer or meditation, the paper suggests permitting their clinical use when such spiritual practices would otherwise serve as treatment, provided threshold of disease severity or functional impairment is met.

Comments

No comments yet.

Log in to comment